Evidence map›Paper›PMID 25710496›Full record

ArticlePLoS pathogens2015

The neurotrophic receptor Ntrk2 directs lymphoid tissue neovascularization during Leishmania donovani infection.

Jane E Dalton, Amy C Glover, Laura Hoodless, Eng-Kiat Lim, Lynette Beattie, Alun Kirby, Paul M Kaye

Open access · goldAbstract read
In one paragraph

Article in PLoS pathogens, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 21 papers.

0numbers the graph read from it
0cells of the map it votes in
21citing papers in PubMed
0.8field-weighted citation impact, top 24% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

21 citing papers in PubMed, 27 citations in OpenAlex.

  1. Review
  2. Article
  3. Vital Role of Visceral Adipose Tissue in Maintaining Cognitive Functions.International journal of molecular sciences · 2025
    Review
  4. Isoform-Specific Roles of NTRK2 in Pulmonary Vascular Regeneration.bioRxiv : the preprint server for biology · 2025
    Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Review
  12. Article
  13. Life science alliance · 2020
    Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Infection and immunity · 2019
    Article
  19. Article
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 2 institutions in 1 country.

Jane E DaltonCentre for Immunology and Infection, Department of Biology and Hull York Medical School, University of York, York, United Kingdom.
Amy C GloverJack Birch Unit, Department of Biology, University of York, York, United Kingdom.
Laura HoodlessCentre for Immunology and Infection, Department of Biology and Hull York Medical School, University of York, York, United Kingdom.
Eng-Kiat LimCentre for Immunology and Infection, Department of Biology and Hull York Medical School, University of York, York, United Kingdom.
Lynette BeattieCentre for Immunology and Infection, Department of Biology and Hull York Medical School, University of York, York, United Kingdom.
Alun KirbyCentre for Immunology and Infection, Department of Biology and Hull York Medical School, University of York, York, United Kingdom.
Paul M KayeCentre for Immunology and Infection, Department of Biology and Hull York Medical School, University of York, York, United Kingdom.
Hull York Medical School · GBUniversity of York · GB

Funding

Medical Research Council G1000230
6 · The paper itself

Abstract

The neurotrophic tyrosine kinase receptor type 2 (Ntrk2, also known as TrkB) and its ligands brain derived neurotrophic factor (Bdnf), neurotrophin-4 (NT-4/5), and neurotrophin-3 (NT-3) are known primarily for their multiple effects on neuronal differentiation and survival. Here, we provide evidence that Ntrk2 plays a role in the pathologic remodeling of the spleen that accompanies chronic infection. We show that in Leishmania donovani-infected mice, Ntrk2 is aberrantly expressed on splenic endothelial cells and that new maturing blood vessels within the white pulp are intimately associated with F4/80(hi)CD11b(lo)CD11c(+) macrophages that express Bdnf and NT-4/5 and have pro-angiogenic potential in vitro. Furthermore, administration of the small molecule Ntrk2 antagonist ANA-12 to infected mice significantly inhibited white pulp neovascularization but had no effect on red pulp vascular remodeling. We believe this to be the first evidence of the Ntrk2/neurotrophin pathway driving pathogen-induced vascular remodeling in lymphoid tissue. These studies highlight the therapeutic potential of modulating this pathway to inhibit pathological angiogenesis.

Indexed as

AnimalsAzepinesBenzamidesBrain-Derived Neurotrophic FactorCell LineEndothelial CellsFemaleLeishmania donovaniLeishmaniasis, VisceralMacrophagesMembrane GlycoproteinsMiceMice, Inbred BALB CMice, KnockoutNeovascularization, PhysiologicProtein-Tyrosine KinasesANA 12 compoundAzepinesBenzamidesBrain-Derived Neurotrophic FactorMembrane Glycoproteinsneurotrophin 4(5) receptorNtrk2 protein, mouseProtein-Tyrosine KinasesReceptors, Nerve Growth FactorReceptor, trkB

Identifiers

PMID25710496
PMCPMC4339582
OpenAlexW2067152290

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.